93 related articles for article (PubMed ID: 15890238)
1. Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells.
Yanamoto S; Iwamoto T; Kawasaki G; Yoshitomi I; Baba N; Mizuno A
Cancer Lett; 2005 Jun; 223(1):67-76. PubMed ID: 15890238
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells.
Huang SL; Wu Y; Yu H; Zhang P; Zhang XQ; Ying L; Zhao HF
Acta Pharmacol Sin; 2006 Feb; 27(2):242-8. PubMed ID: 16412276
[TBL] [Abstract][Full Text] [Related]
3. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
Matsushita S; Ikeda R; Fukushige T; Tajitsu Y; Gunshin K; Okumura H; Ushiyama M; Akiyama S; Kawai K; Takeda Y; Yamada K; Kanekura T
J Dermatol Sci; 2012 Oct; 68(1):19-24. PubMed ID: 22902076
[TBL] [Abstract][Full Text] [Related]
4. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
[TBL] [Abstract][Full Text] [Related]
5. Silencing hexokinase II gene sensitizes human colon cancer cells to 5-fluorouracil.
Peng Q; Zhou J; Zhou Q; Pan F; Zhong D; Liang H
Hepatogastroenterology; 2009; 56(90):355-60. PubMed ID: 19579598
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
7. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
9. [Effect of silencing of hyaluronidase gene HYAL1 by RNA interference on proliferation of human breast cancer cells].
Tan JX; Ren GS; Tu G; Li XT; Wang XY; Ran L
Ai Zheng; 2006 Jul; 25(7):844-8. PubMed ID: 16831275
[TBL] [Abstract][Full Text] [Related]
10. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
Niu J; Xu Z; Li XN; Han Z
Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells.
Tsai MH; Chen X; Chandramouli GV; Chen Y; Yan H; Zhao S; Keng P; Liber HL; Coleman CN; Mitchell JB; Chuang EY
Oncogene; 2006 Jan; 25(4):622-32. PubMed ID: 16247478
[TBL] [Abstract][Full Text] [Related]
12. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
Liu X; Zhou B; Xue L; Shih J; Tye K; Lin W; Qi C; Chu P; Un F; Wen W; Yen Y
Clin Cancer Res; 2006 Nov; 12(21):6337-44. PubMed ID: 17085643
[TBL] [Abstract][Full Text] [Related]
13. Methionine inhibits cellular growth dependent on the p53 status of cells.
Benavides MA; Oelschlager DK; Zhang HG; Stockard CR; Vital-Reyes VS; Katkoori VR; Manne U; Wang W; Bland KI; Grizzle WE
Am J Surg; 2007 Feb; 193(2):274-83. PubMed ID: 17236862
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase small subunit p53R2 promotes oral cancer invasion via the E-cadherin/beta-catenin pathway.
Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Yoshida H; Mizuno A
Oral Oncol; 2009 Jun; 45(6):521-5. PubMed ID: 18804405
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
16. S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.
He Z; Gao J; Wang Q; Liu M; Li Y; Li X; Tang H; Zheng J
Oncol Rep; 2008 Aug; 20(2):325-32. PubMed ID: 18636193
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage.
Lembo D; Donalisio M; Cornaglia M; Azzimonti B; Demurtas A; Landolfo S
Virus Res; 2006 Dec; 122(1-2):189-93. PubMed ID: 16872707
[TBL] [Abstract][Full Text] [Related]
18. [Effect of RNAi-mediated gene silencing of C-erbB-2 on proliferation of lung adenocarcinoma cell line calu-3].
Ren SH; Zhang W; Qu P; Liu Y; Wang JW; Zhang L
Ai Zheng; 2005 Oct; 24(10):1173-8. PubMed ID: 16219128
[TBL] [Abstract][Full Text] [Related]
19. Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells.
Sun YL; Zhou GY; Li KN; Gao P; Zhang QH; Zhen JH; Bai YH; Zhang XF
Neoplasma; 2006; 53(1):1-8. PubMed ID: 16416005
[TBL] [Abstract][Full Text] [Related]
20. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
